Office of the Director, National Institutes of Health; Notice of Meeting, 13610-13611 [2025-05010]
Download as PDF
<![CDATA[
13610
Federal Register / Vol. 90, No. 56 / Tuesday, March 25, 2025 / Notices
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Fellowships in
Digestive Diseases and Nutrition.
Date: June 12–13, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, Suite
7000A, 6707 Democracy Boulevard,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, National Institute of Diabetes
and Digestive and Kidney Diseases, National
Institutes of Health, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7799, yangj@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 20, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2025–05023 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
National Institute on Drug Abuse;
Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council on Drug Abuse.
The meeting will be held as a virtual
meeting and is open to the public, as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance such as sign language
interpretation or other reasonable
accommodations to view the meeting,
should notify Dr. Gillian Acca via email
at gillian.acca@nih.gov five days in
advance of the meeting. The open
VerDate Sep<11>2014
18:03 Mar 24, 2025
Jkt 265001
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov/).
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Drug Abuse.
Date: May 13, 2025.
Closed: 11:00 a.m. to 12:15 p.m.
Agenda: To review and evaluate grant
applications.
Open: 1:30 p.m. to 5:00 p.m.
Agenda: Presentations and other business
of the Council.
Meeting Format: Virtual Meeting.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892.
Contact Person: Susan R.B. Weiss, Ph.D.,
Director, Division of Extramural Research,
Office of the Director, National Institute on
Drug Abuse, NIH, Three White Flint North,
RM 09D08, 11601 Landsdown Street,
Bethesda, MD 20852, 301–443–6480, sweiss@
nida.nih.gov.
Contact Person: Gillian Acca, Ph.D., Health
Scientist Administrator, Division of
Extramural Research, Office of Extramural
Policy, National Institute on Drug Abuse,
NIH, Three White Flint North, RM 09C70,
11601 Landsdown Street, Bethesda, MD
20852, 301–827–5863, gillian.acca@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to Dr. Gillian Acca via email
at gillian.acca@nih.gov. The statement
should include the name, address, telephone
number and when applicable, the business or
professional affiliation of the interested
person.
Information is also available on the
Institute’s/Center’s home page:
www.drugabuse.gov/NACDA/
NACDAHome.html, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: March 19, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2025–04981 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Altered Cell
Subtypes in Aging and AD/ADRD.
Date: April 8, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute on Aging, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Nijaguna Prasad, Ph.D.,
Scientific Review Officer, National Institute
on Aging, National Institutes of Health, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892,
(301) 496–9667, email: prasadnb@
nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: March 20, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–05008 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Council of Councils.
The meeting will be held as a virtual
meeting and is open to the public as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance or other reasonable
accommodations, to view the meeting
should notify the Contact Person listed
E:\FR\FM\25MRN1.SGM
25MRN1
Federal Register / Vol. 90, No. 56 / Tuesday, March 25, 2025 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
below in advance of the meeting. The
open session will be videocast and can
be accessed from the NIH Videocasting
website (https://videocast.nih.gov/).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Council of Councils.
Date: April 21, 2025.
Open: April 21, 2025, 10:00 a.m. to 12:15
p.m.
Agenda: Welcome and Opening Remarks;
Announcements, and NIH Program Updates;
Presentations; and Other Business of the
Committee.
Place: National Institutes of Health
Building 1, 1 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Closed: April 21, 2025, 12:15 p.m. to 01:15
p.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health
Building 1, 1 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Open: April 21, 2025, 01:15 p.m. to 04:35
p.m.
Agenda: NIH Program Updates;
Presentations; and Other Business of the
Committee.
Place: National Institutes of Health
Building 1, 1 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Franziska Grieder, D.V.M.,
Ph.D., Executive Secretary, Council of
Councils, Director, Office of Research
Infrastructure Programs, Division of Program
Coordination, Planning, and Strategic
Initiatives, Office of the Director, NIH, 6701
Democracy Boulevard, Room 948, Bethesda,
MD 20892, GriederF@mail.nih.gov, 301–435–
0744.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Council of Council’s home page at https://
dpcpsi.nih.gov/council/ where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
VerDate Sep<11>2014
18:03 Mar 24, 2025
Jkt 265001
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: March 20, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–05010 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Termination of Parole Processes for
Cubans, Haitians, Nicaraguans, and
Venezuelans
ACTION:
Notice.
The Department of Homeland
Security (‘‘DHS’’) is terminating the
categorical parole programs for
inadmissible aliens from Cuba, Haiti,
Nicaragua, and Venezuela and their
immediate family members (hereinafter
referred to as ‘‘CHNV parole programs’’)
that DHS announced in 2022 and 2023.
This Federal Register notice is intended
to provide context and guidance to the
public regarding the termination of the
CHNV parole programs and related
employment authorization.
DATES: DHS is terminating the CHNV
parole programs as of March 25, 2025.
The temporary parole period of aliens in
the United States under the CHNV
parole programs and whose parole has
not already expired by April 24, 2025
will terminate on that date unless the
Secretary makes an individual
determination to the contrary. Parolees
without a lawful basis to remain in the
United States following this termination
of the CHNV parole programs must
depart the United States before their
parole termination date.
FOR FURTHER INFORMATION CONTACT:
Ihsan Gunduz, Border and Immigration
Policy, Office of Strategy, Policy, and
Plans, Department of Homeland
Security, 2707 Martin Luther King Jr.
Ave. SE, Washington, DC 20528–0445;
telephone (202) 447–3459 (not a toll-free
number).
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
Over the previous two years, DHS has
implemented programs through which
inadmissible aliens who are citizens or
nationals of designated countries, and
their immediate family members, could
request authorization to travel to the
United States in order to be considered
for parole into the country.1 Under these
1 Implementation of a Parole Process for Cubans,
88 FR 1266 (Jan. 9, 2023); Implementation of a
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
13611
categorical parole programs, potentially
eligible beneficiaries were adjudicated
on a case-by-case basis, for advance
authorization to travel to a U.S. port of
entry (‘‘POE’’) in the interior of the
country to seek a discretionary grant of
parole.
On January 20, 2025, President Trump
issued Executive Order 14165,
‘‘Securing Our Borders.’’ 2 Section 2 of
the Order establishes a policy of the
United States to take all appropriate
action to secure the borders of our
Nation through a range of means,
including deterring and preventing the
entry of illegal aliens into the United
States, and removing promptly all aliens
who enter or remain in violation of
Federal law. Section 7 of the Order
directs the Secretary of Homeland
Security to, consistent with applicable
law, take all appropriate action to
‘‘[t]erminate all categorical parole
programs that are contrary to the
policies of the United States established
in [the President’s] Executive Orders,
including the program known as the
‘Processes for Cubans, Haitians,
Nicaraguans, and Venezuelans.’ ’’
Consistent with the President’s
direction, and for the independent
reasons stated in this notice, this notice
terminates the CHNV parole programs.
Although DHS established the
categorical programs for each country
through a separate notice in the Federal
Register, the justification for the
establishment of each of the four
categorical programs was very similar,3
and the rationale for termination is
largely consistent for all four parole
programs. Thus, DHS is announcing the
termination of all four parole programs
by publishing this single notice in the
Federal Register.
II. DHS Parole Authority
The Immigration and Nationality Act
(‘‘INA’’) confers upon the Secretary of
Homeland Security (‘‘Secretary’’) the
narrow discretionary authority to parole
inadmissible aliens into the United
States ‘‘temporarily under such
conditions as [DHS] may prescribe only
on a case-by-case basis for urgent
Change to the Parole Process for Cubans, 88 FR
26329 (Apr. 28, 2023); Implementation of a Parole
Process for Haitians, 88 FR 1243 (Jan. 9, 2023);
Implementation of a Change to the Parole Process
for Haitians, 88 FR 26327 (Apr. 28, 2023);
Implementation of a Parole Process for Nicaraguans,
88 FR 1255 (Jan. 9, 2023); Implementation of a
Parole Process for Venezuelans, 87 FR 63507 (Oct.
19, 2022); Implementation of Changes to the Parole
Process for Venezuelans, 88 FR 1279 (Jan. 9, 2023).
2 See Executive Order 14165, Securing Our
Borders, 90 FR 8467 (Jan. 20, 2025) (published Jan.
30, 2025).
3 Compare, e.g., 88 FR at 1260–63, with 88 FR at
1248–52 (setting out the justifications for the parole
programs for Nicaragua and Haiti, respectively).
E:\FR\FM\25MRN1.SGM
25MRN1
]]>Agencies
[Federal Register Volume 90, Number 56 (Tuesday, March 25, 2025)]
[Notices]
[Pages 13610-13611]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-05010]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Council of
Councils.
The meeting will be held as a virtual meeting and is open to the
public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations,
to view the meeting should notify the Contact Person listed
[[Page 13611]]
below in advance of the meeting. The open session will be videocast and
can be accessed from the NIH Videocasting website (https://videocast.nih.gov/).
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Council of Councils.
Date: April 21, 2025.
Open: April 21, 2025, 10:00 a.m. to 12:15 p.m.
Agenda: Welcome and Opening Remarks; Announcements, and NIH
Program Updates; Presentations; and Other Business of the Committee.
Place: National Institutes of Health Building 1, 1 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Closed: April 21, 2025, 12:15 p.m. to 01:15 p.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health Building 1, 1 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Open: April 21, 2025, 01:15 p.m. to 04:35 p.m.
Agenda: NIH Program Updates; Presentations; and Other Business
of the Committee.
Place: National Institutes of Health Building 1, 1 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Franziska Grieder, D.V.M., Ph.D., Executive
Secretary, Council of Councils, Director, Office of Research
Infrastructure Programs, Division of Program Coordination, Planning,
and Strategic Initiatives, Office of the Director, NIH, 6701
Democracy Boulevard, Room 948, Bethesda, MD 20892,
[email protected], 301-435-0744.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Council of Council's home
page at https://dpcpsi.nih.gov/council/ where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: March 20, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-05010 Filed 3-24-25; 8:45 am]
BILLING CODE 4140-01-P
